Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Floxapen 250mg/5ml syrup
0501012H0BBABAB
|
Floxapen (Liquid/Powder) | Flucloxacillin magnesium | Infections | 1 |
|
Flucloxacillin 250mg/5ml oral suspension
0501012H0AAABAB
|
Flucloxacillin magesium | Flucloxacillin magnesium | Infections | 1 |
|
Floxapen 125mg/5ml syrup
0501012H0BBAAAA
|
Floxapen (Liquid/Powder) | Flucloxacillin magnesium | Infections | No data available |
|
Flucloxacillin 125mg/5ml oral suspension
0501012H0AAAAAA
|
Flucloxacillin magesium | Flucloxacillin magnesium | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.